Reference priceBRL R$22.75Original source price: INR 350.00. Converted estimates are available by currency selection.
| Brand | Livmarli |
|---|---|
| Manufacturer | Mirum Pharmaceuticals |
| Prescription required | Yes |
Livmarli 9.5mg/ml oral solution,1bottle x 30ml(maralixibat)
maralixibat
Description
Livmarli 9.5mg/ml oral solution,1bottle x 30ml(maralixibat) is a medicine catalog record in the MediPriceHub database. Active ingredient: maralixibat. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: Mirum Pharmaceuticals. Therapeutic category: Medicine Library > Liver and Gallbladder Diseases > Cholestatic liver disease. Pack information: 9.5 / 30. Origin country or market: United States. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
LIVMARLI is an ileal bile acid transporter (IBAT) inhibitor indicated for: • the treatment of cholestatic pruritus in patients 3 months of age and older with Alagille syndrome (ALGS). • the treatment of cholestatic pruritus in patients 12 months of age and older with progressive familial intrahepatic cholestasis (PFIC). o Limitations of Use: LIVMARLI is not recommended in a subgroup of PFIC type 2 patients with specific ABCB11 variants resulting in non-functional or complete absence of bile salt export pump (BSEP) protein. o Limitations of Use: LIVMARLI is not recommended in a subgroup of PFIC type 2 patients with specific ABCB11 variants resulting in non-functional or complete absence of bile salt export pump (BSEP) protein.How to Use
Use maralixibat under the supervision of a qualified healthcare professional. Take it by mouth only according to the approved label and the dose prescribed by a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: maralixibat. Pack size: 9.5 / 30. Pack unit: bottle. Manufacturer: Mirum Pharmaceuticals. Origin country: United States. Source category: Medicine Library > Liver and Gallbladder Diseases > Cholestatic liver disease. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
The available source record does not provide a clean, product-specific adverse-reaction list. Potential risks depend on the active ingredient, dose, route, treatment duration, and patient condition. Check the approved local prescribing information for the complete adverse-reaction profile, warnings, contraindications, and monitoring requirements. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, serious bleeding, or rapidly worsening symptoms.Esta informação é apenas para referência. Consulte um profissional de saúde antes de usar qualquer medicamento.